ADAP Shares

Adaptimmune Therapeutics Plc ADR (ADAP) with a beta value of 2.37 appears to be a promising investment opportunity.

Sana Meer

On Friday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) opened higher 15.75% from the last session, before settling in for the ...

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.